echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Essence pharmaceutical: 10 to 10, 1.5.

    Essence pharmaceutical: 10 to 10, 1.5.

    • Last Update: 2020-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    pharmaceuticals network February 6th hearing announcement on the 5 night of essence pharmaceuticals, the company received the proposal and commitment of "2016 profit allocation and capital reserve fund conversion plan" submitted by the controlling shareholder Nantong Industrial Holdings Group Limited to the board of directors in February 4, 2017< br / > < br / > < br / > < br / > the plan shows that the company plans to distribute a cash dividend of RMB 1.50 (including tax) per 10 shares to all shareholders based on the total capital stock of 420294831 shares as of December 31, 2016; at the same time, it plans to increase 10 shares to all shareholders based on the capital reserve
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.